[The role of autoimmune process in the pathogenesis of hemorrhagic stroke].

Using immunologic study along with clinical and neurological ones, 104 patients in acute stage of hemorrhage stroke (18% of them with subarachnoidal; 27%--with parenchymatous and 55%--with combined hemorrhage) have been examined. A level of antibodies to DNA (anti-DNA) was determined in cerebrospinal fluid (CSF) and blood serum on 1, 10 and 20 days. Control group consisted of 20 persons.